TITLE

Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study

AUTHOR(S)

Schweizer, Marin L.; Furuno, Jon P.; Harris, Anthony D.; Johnson, J. Kristie; Shardell, Michelle D.; McGregor, Jessina C.; Thom, Kerri A.; Sakoulas, George; Perencevich, Eli N.

PUB. DATE

July 2010

SOURCE

PLoS ONE;2010, Vol. 5 Issue 7, p1

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Background: Appropriate empiric therapy, antibiotic therapy with in vitro activity to the infecting organism given prior to confirmed culture results, may improve Staphylococcus aureus outcomes. We aimed to measure the clinical impact of appropriate empiric antibiotic therapy on mortality, while statistically adjusting for comorbidities, severity of illness and presence of virulence factors in the infecting strain. Methodology: We conducted a retrospective cohort study of adult patients admitted to a tertiary-care facility from January 1, 2003 to June 30, 2007, who had S. aureus bacteremia. Time to appropriate therapy was measured from blood culture collection to the receipt of antibiotics with in vitro activity to the infecting organism. Cox proportional hazard models were used to measure the association between receipt of appropriate empiric therapy and in-hospital mortality, statistically adjusting for patient and pathogen characteristics. Principal Findings: Among 814 admissions, 537 (66%) received appropriate empiric therapy. Those who received appropriate empiric therapy had a higher hazard of 30-day in-hospital mortality (Hazard Ratio (HR): 1.52; 95% confidence interval (CI): 0.99, 2.34). A longer time to appropriate therapy was protective against mortality (HR: 0.79; 95% CI: 0.60, 1.03) except among the healthiest quartile of patients (HR: 1.44; 95% CI: 0.66, 3.15). Conclusions/Significance: Appropriate empiric therapy was not associated with decreased mortality in patients with S. aureus bacteremia except in the least ill patients. Initial broad antibiotic selection may not be widely beneficial.

ACCESSION #

52884311

Tags: MEDICINE, Empirical;  ANTIBIOTICS;  THERAPEUTICS;  MORTALITY;  STAPHYLOCOCCUS aureus;  COHORT analysis;  OLDER patients;  PROPORTIONAL hazards models;  BACTEREMIA

 

Related Articles

• Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. G�mez, J.; Garc�a-V�zquez, E.; Ba�os, R.; Canteras, M.; Ruiz, J.; Ba�os, V.; Herrero, J. A.; Vald�s, M. // European Journal of Clinical Microbiology & Infectious Diseases;Apr2007, Vol. 26 Issue 4, p239 

  The objective of this study was to evaluate prognostic factors and the influence of different empiric antibiotic therapies on outcome and mortality in a cohort of 100 inpatients with bacteraemia (84 cases nosocomial) caused by methicillin-resistant Staphylococcus aureus (MRSA). Patients were...

• Therapy of Staphylococcus aureus Bacteremia Associated with a Removable Focus on Infection. Iannini, Paul B.; Crossley, Kent // Annals of Internal Medicine;May76, Vol. 84 Issue 5, p558 

  Presents a study which investigated the duration or therapy necessary to eradicate Staphylococcus aureus bacteremia in patients with removable source of infection. Methodology; Results of the study.

• Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia. Lodise, Thomas P.; McKinnon, Peggy S.; Swiderski, Linda; Rybak, Michael J. // Clinical Infectious Diseases;6/1/2003, Vol. 36 Issue 11, p1418 

  The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001....

• The association between alcohol consumption and mortality: the Swedish women's lifestyle and health study. Behrens, Gundula; Leitzmann, Michael; Sandin, Sven; L�f, Marie; Heid, Iris; Adami, Hans-Olov; Weiderpass, Elisabete // European Journal of Epidemiology;Feb2011, Vol. 26 Issue 2, p81 

  lthough light to moderate alcohol intake may reduce cardiovascular disease (CVD) mortality, the effect on total mortality requires further study, particularly among young and middle-aged women. We studied the association between alcohol consumption and mortality from all causes, from cancer, and...

• Random effects Cox models: A Poisson modelling approach. Ma, Renjun; Krewski, Daniel; Burnett, Richard T. // Biometrika;Mar2003, Vol. 90 Issue 1, p157 

  We propose a Poisson modelling approach to nested random effects Cox proportional hazards models. An important feature of this approach is that the principal results depend only on the first and second moments of the unobserved random effects. The orthodox best linear unbiased predictor approach...

• Linking period and cohort life-expectancy linear increases in Gompertz proportional hazards models. Missov, Trifon I.; Lenart, Adam // Demographic Research;Jan-Jun2011, Vol. 24, p455 

  In a Gompertz mortality model with constant yearly improvements at all ages, linear increases in period life expectancy correspond to linear increases in the respective cohort life expectancy. The link between the two measures can be given by a simple approximate relationship.

• Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Maria I. Danila; Guillermo J. Pons-Estel; Jie Zhang; Luis M. Vil�; John D. Reveille; Graciela S. Alarc�n // Rheumatology;May2009, Vol. 48 Issue 5, p542 

  Objective. Damage accrual in SLE has been previously shown to be an independent predictor of mortality. We sought to discern which SLICC Damage Index (SDI) domains are the most important predictors of survival in SLE. Methods. SLE patients (ACR criteria), age ?16 years, disease duration ?5 years...

• Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort. Fisher, G; Yang, Z H; Kudahetti, S; Møller, H; Scardino, P; Cuzick, J; Berney, D M // British Journal of Cancer;2/5/2013, Vol. 108 Issue 2, p271 

  Background:Standard clinical parameters cannot accurately differentiate indolent from aggressive prostate cancer. Our previous work showed that immunohistochemical (IHC) Ki-67 improved prediction of prostate cancer death in a cohort of conservatively treated clinically localised prostate cancers...

• All-Cause and Disease-Specific Mortality in Hospitalized Patients With Clostridium difficile Infection: A Multicenter Cohort Study. Hensgens, Marjolein P. M.; Goorhuis, Abraham; Dekkers, Olaf M.; van Benthem, Birgit H. B.; Kuijper, Ed J. // Clinical Infectious Diseases;Apr2013, Vol. 56 Issue 8, p1108 

  Mortality among patients with Clostridium difficile infection (CDI) is high, even in an endemic situation. CDI is associated with a 2.5-fold increase in 30-day mortality. This report highlights the considerable disease burden and clinical impact of CDI, even in absence of an outbreak.Background....

Read the Article